SCHEDULE 13G/A: Todd Hale Morrison Discloses 8.67% Passive Stake in BioRestorative Therapies, Inc.
Beneficial Ownership Disclosure
Todd Hale Morrison has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.67% of BioRestorative Therapies, Inc.'s common stock as of February 10, 2025.
Summary
- The filing is an Amendment No. 1 to Schedule 13G for BioRestorative Therapies, Inc. (Issuer).
- The Reporting Person is Todd Hale Morrison, a United States citizen.
- As of the close of business on February 10, 2025, Todd Hale Morrison beneficially owned 600,000 shares of BioRestorative Therapies, Inc. common stock.
- This ownership represents approximately 8.67% of the Issuer's outstanding Common Stock.
- The percentage calculation is based on 6,919,919 shares of Common Stock outstanding as of November 12, 2024, as reported in the Issuer's Form 10-Q.
- The Reporting Person holds shared voting power and shared dispositive power over all 600,000 beneficially owned shares.
- The securities were acquired and are held for passive investment purposes, not with the intent to change or influence control of the Issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, providing no direct positive or negative sentiment regarding the company's operational or financial performance.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the Issuer's future operations or financial performance.
Industry Context
This filing is a standard disclosure of a significant passive ownership stake in a publicly traded company, common across all industries for investors holding more than 5% of a company's stock.
Stakeholder Impact
- Shareholders: Disclosure of a significant passive investor may provide some confidence regarding the stock's liquidity and investor interest, though the filing itself does not imply active engagement with management.
Key Dates
| Date | Description |
|---|---|
| 11/12/2024 | Date of Issuer's Form 10-Q filing, reporting 6,919,919 shares outstanding, used for percentage calculation. |
| 02/10/2025 | Date of event requiring filing of this statement and the date of filing. |
Keywords
BioRestorative Therapies, BRTX, Todd Hale Morrison, Schedule 13G, beneficial ownership, common stock, SEC filing, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.